Sanofi's Dupixent Secures EU Approval as Novel COPD Therapy
Jul 4, 2024
Copd Equities
Amgen and AstraZeneca Showcase Efficacy of Tezspire in Treating COPD Across Diverse Patients
May 21, 2024